People · Operator
Named in public records as an officer, director or promoter · active 2015–2023 · Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BioIQ, Inc. | — | Other | Series B | $59.6M | $232.6M | 2015 |
| TriVirum, Inc. | — | Other Technology | Series A | $14.5M | $78.5M | 2023 |
Justin Bellante at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Justin Bellante on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Midler | 1 | 6 |
| Paul McCreadie | 1 | 6 |
| Todd Creech | 1 | 4 |
| Brandon Cady | 1 | 4 |
| YASMIN SEYAL | 1 | 3 |
| Brent Peus | 1 | 3 |
| Bill Willis | 1 | 3 |
| Kenneth Buechler | 1 | 3 |
| Brent J. Peus | 1 | 2 |
| Mike Cotton | 1 | 2 |
| Justin J. Bellante | 1 | 2 |
| Christian Renaudin | 1 | 2 |
| Pete Desai | 1 | 2 |
| Patrick Cua | 1 | 2 |
| Phil B Harmon | 1 | 1 |
| Lawrence B Gray | 1 | 1 |
| Jeff Closs | 1 | 1 |
| Kathleen Shanahan | 1 | 1 |
| Jeff J. Closs | 1 | 1 |
| Jason J. Torres | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.